Clinicians should not treat weight loss and glycemic control as separate goals
Regulatory labels and indication-specific trials drive prescribing, monitoring, and coverage, and GLP-1 medications accounted for 45% of the total diabetes drug market in 2023, making label strategy a core clinical and payer lever
Calcium sources include dairy, fortified plant milks and leafy greens
Keeping easy-to-digest, protein-rich snacks readily availablesuch as cheese, nuts, hard-boiled eggs, or protein barsensures patients can maintain nutrition even when appetite is minimal
Treatment with the serine protease inhibitor camostat, which inhibits, among other proteases, TMPRSS2, reduced glucose-stimulated GIP secretion in GLUTag cells (34), whereas treatment with the FXa-specific inhibitor rivaroxaban showed no significant difference (Figure 2C)
Shock, 40 (4), 281